Pharmacogenomics of Atherosclerotic Plaque: Pathophysiological Background and Therapeutic Perspectives

Alfredo Mauriello, Aldo De Falco, Adriana Correra, Antonello D’Andrea, Francesco Giallauria, Antonio Giordano, Vincenzo Russo · 2026

Read Pharmacogenomics of Atherosclerotic Plaque: Pathophysiological Background and Therapeutic Perspectives by Alfredo Mauriello, Aldo De Falco, Adriana Correra, Antonello D’Andrea, Francesco Giallauria, Antonio Giordano, Vincenzo Russo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13194203.txt.

Description

Alfredo Mauriello and co-authors review how a patient's genes shape care for clogged arteries. Their 2026 paper covers pharmacogenomics, the study of gene-driven drug response, in atherosclerosis. Heart and vessel disease still kills more people than any other cause. The review centers on two drug families: blood thinners that stop clots and statins that lower blood fats. Gene-guided choices already have trial backing in one key setting.

Patients getting artery stents after heart treatment fare better when thinner choice follows their genes. Other gene variants explain why some patients quit statins over muscle pain. Still other variants blunt response to a newer fat-lowering drug class. The authors argue gene reads can tailor care, cut waste, and spur new drugs. In a field this deadly, small per-patient gains scale to large public gains.

Catalog record

CREATORAlfredo Mauriello, Aldo De Falco, Adriana Correra, Antonello D’Andrea, Francesco Giallauria, Antonio Giordano, Vincenzo Russo
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE49 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13194203

Browse the full library · About the Tower of Babel